TABLE 3.
Total antibody and antibody subtype levels at days 7, 21, and 28 after intraperitoneal HBsAg vaccine administration to mice treated with clarithromycin, doxycycline, ampicillin, or NS
| Day postvaccination | Antibody subtype | Serum dilution | Antibody level (A492)
|
|||||
|---|---|---|---|---|---|---|---|---|
| Mean for group treated
with:
|
SEM (pooled) | Critical value | ||||||
| Clarithromycin (n = 10) | Doxycycline (n = 10) | Ampicillin (n = 10) | NS (n = 10) | |||||
| 7 | Total | 1:100 | 0.203 | 0.212 | 0.200 | 0.193 | 0.016 | 0.060 |
| IgM | 1:100 | 0.357a | 0.103ab | 0.201 | 0.322b | 0.029 | 0.210 | |
| IgG1 | 1:50 | 0.027 | 0.026 | 0.026 | 0.027 | 0.002 | 0.007 | |
| IgG2a | 1:50 | 0.022 | 0.020 | 0.020 | 0.021 | 0.002 | 0.008 | |
| 21 | Total | 1:100 | 0.293 | 0.466 | 0.506 | 0.721 | 0.143 | 0.543 |
| IgM | 1:100 | 0.382 | 0.598 | 0.502 | 0.560 | 0.064 | 0.245 | |
| IgG1 | 1:50 | 0.049 | 0.069 | 0.123 | 0.222 | 0.060 | 0.229 | |
| IgG2a | 1:50 | 0.060 | 0.039 | 0.099 | 0.162 | 0.045 | 0.172 | |
| 28 | Total | 1:1,000 | 0.440 | 0.631 | 0.789 | 0.785 | 0.106 | 0.405 |
| IgM | 1:100 | 0.379cde | 0.602c | 0.565d | 0.574e | 0.041 | 0.158 | |
| IgG1 | 1:50 | 0.335 | 0.710 | 1.056 | 1.130 | 0.222 | 0.845 | |
| IgG2a | 1:50 | 0.464 | 0.339 | 0.565 | 0.626 | 0.140 | 0.533 | |
a–e The difference is statistically significant compared to the mean with the same superscript.